ArticleInterdisciplinary cardiovascular and thoracic surgery2024
Major pathologic response predicts survival in resectable stage IIIA non-small cell lung cancer after neoadjuvant therapy.
Shihong Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.